Hemogenyx Pharmaceuticals is a publicly traded company (LSE:HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City ...
You might think flying cars are the stuff of The Jetsons, but one Austrian company is going so far as to get ahead of your biggest questions about engine failure, mid-air maneuvering, and even ...
To address the existing challenges with CAR T-cell therapy, scientists at Umoja Biopharma Inc. developed the Vivovec platform, which is an off-the-shelf surface-engineered lentiviral vector (LVV) drug ...
CDMO's Cell and Gene Center of Excellence Achieves fifth commercial viral vector product approval, and second overall from FDA in 2024 SEATTLE, WA and MILAN, ITALY / ACCESSWIRE / December 12, 2024 / ...
ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stage MONT-SAINT-GUIBERT, Belgium, Dec. 11, 2024 (GLOBE NEWSWIRE) -- EsoBiotec SA, a biotechnology company empowering cells in ...
Kite, a Gilead Company , announced results today from four analyses that continue to demonstrate the durability of response of Tecartus® (brexucabtagene autoleucel) in patients with ...